SCN9A

gene product
ETHA, Nav1.7, NE-NA, NENA, PN1
This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
457 antibodies from 32 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Abnova Corporation
3 antibodies
Novus Biologicals
19 antibodies
antibodies-online
147 antibodies
GeneTex
5 antibodies
LifeSpan BioSciences, Inc.
63 antibodies
NovoPro Bioscience Inc.
3 antibodies
Biorbyt
43 antibodies
Antibodies Incorporated
2 antibodies
Rockland Immunochemicals, Inc.
1 antibody
OriGene
7 antibodies
Bioworld Technology, Inc
3 antibodies
Invitrogen Antibodies
4 antibodies
Proteintech Group
1 antibody
Cell Signaling Technology, Inc
2 antibodies
Affinity Biosciences
1 antibody
Abbkine Scientific Co.Ltd.
1 antibody
Aviva Systems Biology
1 antibody
Creative Biolabs
49 antibodies
Atlas Antibodies
1 antibody
MyBioSource
6 antibodies
Acris Antibodies GmbH
2 antibodies
UC Davis/NIH NeuroMab Facility
2 antibodies
Creative Diagnostics
4 antibodies
Abgent
3 antibodies
St John's Laboratory
2 antibodies
United States Biological
62 antibodies
EMD Millipore
3 antibodies
Sigma-Aldrich
2 antibodies
Everest Biotech
1 antibody
RayBiotech, Inc.
1 antibody
ProSci
1 antibody